Nadolol recalls

The FDA has published 3 recalls involving Nadolol since 2015. The latest was reported on 2 Jun 2021. Most were for sterility. Cardinal Health has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2015

Last 12 months0reported

Class I00% of total

Ongoing0latest 2 Jun 2021

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 3 100%Class III 0 0%

Why nadolol is recalled

Companies

By year

2021133%
2017133%
2015133%

All nadolol recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
2 Jun 2021Drug	CLASS II	Nadolol Tablets, USP 40 mg recalled by Cardinal HealthNadolol	Cardinal Health	Manufacturing (CGMP) Deviations	FL, GA, SC
4 Jan 2017Drug	CLASS II	Nadolol Tablets, USP, 40mg recalled by Sandoz Incorporated	Sandoz	Potency & Assay	MS, OH
20 May 2015Drug	CLASS II	Nadolol 10 mg/ Susp, Health Innov Pharmacy recalled	Health Innovations Pharmacy	Sterility	NC

Should you stop taking Nadolol?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.